Syndecan-1 overexpression is associated with nonluminal subtypes and poor prognosis in advanced breast cancer.

Nguyen TL, Grizzle WE, Zhang K, Hameed O, Siegal GP, Wei S
Am J Clin Pathol. 2013 140 (4): 468-74

PMID: 24045542 · DOI:10.1309/AJCPZ1D8CALHDXCJ

MeSH Terms (19)

Adult Aged Aged, 80 and over Biomarkers, Tumor Breast Neoplasms Carcinoma, Ductal, Breast Carcinoma, Lobular Female Humans Lymphatic Metastasis Lymph Nodes Middle Aged Neoplasm Grading Prognosis Proportional Hazards Models Survival Rate Syndecan-1 Tennessee Tissue Array Analysis

Connections (1)

This publication is referenced by other Labnodes entities:

Links